| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1
* Department of Medicine 0682, University of California San Diego, La Jolla, California, USA; and
Department of Medicine, Federico II University of Naples, 80131 Naples, Italy
1Correspondence: Department of Medicine, 0682, University of California, San Diego, 9500 Gilman Dr., MTF 110, La Jolla, CA 92093-0682, USA. E-mail: wpalinski{at}ucsd.edu and cnapoli{at}ucsd.edu
It has long been postulated that pathogenic events during fetal development influence atherosclerosis-related diseases later in life, but the mechanisms involved are unknown. This review focuses on the evidence indicating that maternal hypercholesterolemia during pregnancy is responsible for one cascade of pathogenic events. Maternal hypercholesterolemia is associated with greatly increased fatty streak formation in human fetal arteries and accelerated progression of atherosclerosis during childhood. Recent experiments in genetically more homogeneous rabbits established that temporary diet-induced maternal hypercholesterolemia is sufficient to enhance fetal lesion formation. More important, maternal hypercholesterolemia or ensuing pathogenic events in the fetus increase postnatal atherogenesis in response to hypercholesterolemia. Maternal treatment with cholesterol-lowering agents or antioxidants greatly reduces fetal and postnatal atherogenesis, indicating a pathogenic role of lipid peroxidation and a potential involvement of oxidation-sensitive signaling pathways. Experiments in a murine model showed that differences in arterial gene expression between offspring of normo- and hypercholesterolemic mothers persist long after birth, supporting the assumption that fetal lesion formation is associated with genetic programming, which may in turn affect postnatal atherogenesis. A better understanding of pathogenic programming events in utero may lead to the identification of genes determining the susceptibility to atherosclerosis and define novel preventive approaches.—Palinski, W., Napoli, C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis.
Key Words: fetal lesion • maternal cholesterol level • vitamin E • postnatal gene expression
This article has been cited by other articles:
|
|
 |
|
  S. Wesseling, M. P. Koeners, and J. A. Joles Taurine: Red Bull or Red Herring? Hypertension, June 1, 2009; 53(6): 909 - 911. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Stefulj, U. Panzenboeck, T. Becker, B. Hirschmugl, C. Schweinzer, I. Lang, G. Marsche, A. Sadjak, U. Lang, G. Desoye, et al. Human Endothelial Cells of the Placental Barrier Efficiently Deliver Cholesterol to the Fetal Circulation via ABCA1 and ABCG1 Circ. Res., March 13, 2009; 104(5): 600 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. S. Bhasin, A. van Nas, L. J. Martin, R. C. Davis, S. U. Devaskar, and A. J. Lusis Maternal Low-Protein Diet or Hypercholesterolemia Reduces Circulating Essential Amino Acids and Leads to Intrauterine Growth Restriction Diabetes, March 1, 2009; 58(3): 559 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Brandes Activating SIRT1: a new strategy to prevent atherosclerosis? Cardiovasc Res, November 1, 2008; 80(2): 163 - 164. [Full Text] [PDF]
|
|
|
|
 |
|
 W. Palinski and C. Napoli Impaired Fetal Growth, Cardiovascular Disease, and the Need to Move on Circulation, January 22, 2008; 117(3): 341 - 343. [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Getz and C. A. Reardon Nutrition and Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2499 - 2506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Napoli and L. J Ignarro Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis J. Clin. Pathol., April 1, 2007; 60(4): 341 - 344. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tsimikas, E. S. Brilakis, R. J. Lennon, E. R. Miller, J. L. Witztum, J. P. McConnell, K. S. Kornman, and P. B. Berger Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events J. Lipid Res., February 1, 2007; 48(2): 425 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Ignarro, M. L. Balestrieri, and C. Napoli Nutrition, physical activity, and cardiovascular disease: An update Cardiovasc Res, January 15, 2007; 73(2): 326 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Napoli, L. O. Lerman, F. de Nigris, M. Gossl, M. L. Balestrieri, and A. Lerman Rethinking Primary Prevention of Atherosclerosis-Related Diseases Circulation, December 5, 2006; 114(23): 2517 - 2527. [Full Text] [PDF]
|
|
|
|
 |
|
 P D Gluckman and M A Hanson Adult disease: echoes of the past Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S47 - S50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yamashita, S. Freigang, C. Eberle, J. Pattison, S. Gupta, C. Napoli, and W. Palinski Maternal Immunization Programs Postnatal Immune Responses and Reduces Atherosclerosis in Offspring Circ. Res., September 29, 2006; 99(7): E51 - E64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tsimikas, J. T. Willerson, and P. M. Ridker C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C19 - C31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Crimmins and C. E. Finch Infection, inflammation, height, and longevity PNAS, January 10, 2006; 103(2): 498 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yoshida and Y. Wada Transfer of maternal cholesterol to embryo and fetus in pregnant mice J. Lipid Res., October 1, 2005; 46(10): 2168 - 2174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Kenis, S. Tartakover-Matalon, N. Cherepnin, L. Drucker, A. Fishman, M. Pomeranz, and M. Lishner Simvastatin has deleterious effects on human first trimester placental explants Hum. Reprod., October 1, 2005; 20(10): 2866 - 2872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Armitage, L. Lakasing, P. D. Taylor, A. A. Balachandran, R. I. Jensen, V. Dekou, N. Ashton, J. R. Nyengaard, and L. Poston Developmental programming of aortic and renal structure in offspring of rats fed fat-rich diets in pregnancy J. Physiol., May 15, 2005; 565(1): 171 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Finch and E. M. Crimmins Inflammatory Exposure and Historical Changes in Human Life-Spans Science, September 17, 2004; 305(5691): 1736 - 1739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Boot, R. P.M. Steegers-Theunissen, R. E. Poelmann, L. van Iperen, and A. C. Gittenberger-de Groot Homocysteine Induces Endothelial Cell Detachment and Vessel Wall Thickening During Chick Embryonic Development Circ. Res., March 5, 2004; 94(4): 542 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Schmid, W. S. Davidson, L. Myatt, and L. A. Woollett Transport of cholesterol across a BeWo cell monolayer: implications for net transport of sterol from maternal to fetal circulation J. Lipid Res., October 1, 2003; 44(10): 1909 - 1918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Norman and H. Martin Preterm Birth Attenuates Association Between Low Birth Weight and Endothelial Dysfunction Circulation, August 26, 2003; 108(8): 996 - 1001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Palinski United They Go: Conjunct Regulation of Aortic Antioxidant Enzymes During Atherogenesis Circ. Res., August 8, 2003; 93(3): 183 - 185. [Full Text] [PDF]
|
|
|
|
 |
|
 C Napoli, L O Lerman, V Sica, A Lerman, G Tajana, and F de Nigris Microarray analysis: a novel research tool for cardiovascular scientists and physicians Heart, June 1, 2003; 89(6): 597 - 604. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
